---
document_datetime: 2025-10-24 13:42:16
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/columvi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: columvi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.6120621
conversion_datetime: 2025-12-26 11:51:23.557787
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Columvi

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                           |
|----------------------|----------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|---------------------------------------------------|
| Variation type II /  | This was an application for a group of | 24/07/2025                          |                                             | SmPC,                            | For more information, please refer to the Summary |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000270570   | variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | Labelling and   | of Product Characteristics.   |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------|-------------------------------|
|                     | C.I HUMAN AND VETERINARY MEDICINAL PRODUCTS - C.I.4 Change(s) in the Summary of Product Characteristics, Labelling or Package Leaflet due to new quality, preclinical, clinical or pharmacovigilance data - Accepted C.I HUMAN AND VETERINARY MEDICINAL PRODUCTS - C.I.4 Change(s) in the Summary of Product Characteristics, Labelling or Package Leaflet due to new quality, preclinical, clinical or pharmacovigilance data - Accepted C.I HUMAN AND VETERINARY MEDICINAL PRODUCTS - C.I.4 Change(s) in the Summary of Product Characteristics, Labelling or Package Leaflet due to new quality, preclinical, clinical or pharmacovigilance data - Accepted A grouped application consisting of three Type II variations, as follows: C.I.4: Update of sections 4.2 and 4.4 of the SmPC in order to add information regarding opportunistic infections based on a review of data from clinical trials, post-marketing surveillance, and literature. The Package Leaflet is updated accordingly. C.I.4: | PL              |                               |

<div style=\"page-break-after: always\"></div>

|                                       | to add colitis as an adverse reaction with frequency uncommon based on a review of data from clinical trials, post-marketing surveillance, and literature. The Package Leaflet is updated accordingly. C.I.4: Update of sections 4.8 of the SmPC in order to add information regarding cytomegalovirus infection/reactivation based on a review of data from clinical trials, post- marketing surveillance, and literature. The Package Leaflet is updated accordingly. In addition, the MAH took the opportunity to implement editorial changes to the PI, and to update section 6.6. of the SmPC.   |            |                        |
|---------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------------------|
| Variation type IB / EMA/VR/0000249350 | B.IV.1 Change of a measuring or administration device - B.IV.1.z Other variation - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 26/03/2025 | SmPC, Labelling and PL |